Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors – a single Brazilian center experience

ABSTRACT Objective: The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced differentiated thyroid carcinoma (DTC) refractory to radioactive iodine (RAIR) therapy. Subjects and methods: We reviewed the records of all patients with MKI-...

Full description

Bibliographic Details
Main Authors: Natalia Treistman, Gabriela Maia Nobre, Mariana Yoshii Tramontin, Gabriel Madeira Werberich da Silva, Daniel Herchenhorn, Luiz Henrique de Lima Araujo, Fernanda Accioly de Andrade, Rossana Corbo, Daniel Bulzico, Fernanda Vaisman
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2021-05-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000400411&tlng=en